Goal-Directed vs Traditional Approach to Intraoperative Fluid Therapy during Open Major Bowel Surgery: Is There a...

Area of Science:

• Anesthesiology
• Surgical Care
• Critical Care Medicine

Background:

• Optimizing perioperative fluid therapy is crucial for surgical patient outcomes.
• This study evaluated goal-directed fluid therapy versus traditional methods in open major bowel surgery.

Purpose of the Study:

• To prospectively compare goal-directed intraoperative fluid therapy (using FloTrac and PVI) with traditional fluid therapy.
• To assess the impact on fluid balance, recovery, and complications in general surgical patients.

Main Methods:

• 306 adult patients (ASA I-II) undergoing elective open major bowel surgery were randomized into three groups: control (traditional), FloTrac, and PVI.
• Fluid input/output, recovery metrics, and complications were meticulously recorded.
• Exclusion criteria included laparoscopic surgery and other non-bowel procedures.

Main Results:

• Goal-directed groups (FloTrac, PVI) received significantly less crystalloid and more colloid fluids than the control group.
• Net fluid balance was substantially lower in the FloTrac (1515 ml) and PVI (1420 ml) groups compared to the control group (2500 ml).
• No significant differences were observed in ICU/HDU stay, bowel function, oral intake, morbidity, hospital duration, or survival rates. Anastomotic leaks were slightly more frequent in the control group.

Conclusions:

• Goal-directed fluid management with FloTrac or PVI effectively reduces intraoperative fluid administration and net fluid balance.
• The complication rates were comparable across all three fluid therapy strategies.
• This suggests that while goal-directed therapy optimizes fluid administration, it does not alter overall complication profiles in this patient population.